Objectives: The aims of the study were to investigate the distribution and the antibiotic resistance profiles of the microorganisms isolated from outpatients with lower urinary tract infection (UTI) during 2011-2012 period and to determine the most appropriate empirical therapy choices. Materials and Methods: Culture and susceptibility test results of 14.096 urine samples sent from outpatient clinics with presumptive lower UTI diagnosis in the last year (2011)(2012) pneumoniae. Among oral antibiotics tested, nitrofurantoin (NF) had the lowest resistance rates for both Gram-positive and Gram-negative isolates with 2.7% and 12.1%, respectively. Ampicillin for Grampositives and Cefuroxim for Gram-negatives were other oral drugs with the lowest resistance rates with 6.3% and 25.9%, respectively. Conclusion: NF appears as the most effective oral drug for adult outpatients with UTI. Cefuroxim can be considered as the second effective choice because ampicillin-sensitive Gram-positive isolates (except Enterococcus spp) would also be sensitive to it. NF and trimethoprim-sulfamethoxazole (TMP-SMX) is suggested as first or second choice in UTI treatment in antimicrobial therapy guidelines like Sanford and IDSA. However, TMP-SMX resistance was found 35% in our population; consequently it is not a suitable option for our patients. Key words: Urinary tract infection, antibiotic resistance, enterobactericeae, ESBL, empirical treatment Öz Amaç: Çalışmamızın amaçları, 2011-2012 tarihleri arasında, alt üriner sistem enfeksiyonu (ÜSE) tanılı poliklinik hastalarından izole edilen mikroorganizmaların dağılımı, antibiyotik direnç profillerinin araştırılması ve uygun ampirik tedavi seçeneklerinin belirlenmesidir. Materyal ve Metot: 2011-2012 tarihleri arasında, hastanemiz polikliniklerinden alt ÜSE ön tanısı ile gönderilen 14096 idrar örneğinin kültür / antibiyogram sonuçları retrospektif olarak değerlendirildi. Tekrarlayan üremeler hariç tutularak toplam 2005 örnekteki üremeler değerlendirmeye alındı. Kültür ve identifikasyon testleri konvansiyonel/yarı otomatik ve otomatik yöntemlerle yapıldı. Antibiyotik duyarlılık testleri CLSI (Clinical Laboratory Standarts Institute) önerileri doğrultusunda Kirby-Bauer disk difüzyon yöntemiyle gerçekleştirildi. Bulgular: Örneklerin %83,7'sinde Enterobacteriaceae üyeleri üredi. Bunların 1287'si (%64,2) E.coli; 238'i (%11,9) K.pneumoniae idi. Toplam 67 (%3,3) örnekte P.aeruginosa üredi. Gram-pozitif üremelerin oranı; 55'i (%2,7) metisiline dirençli koagülaz negatif stafiolokok, 55'i (%2,7) E.faecalis, 49'u (%2,4) S.agalactia v.b. olmak üzere %12,86 idi. Genişlemiş spektrumlu beta laktamaz prevalansı E.coli izolatlarında %23,2; K.pneumonia izolatlarında %25,4 olarak belirlendi. Gerek Gram-pozitif, gerekse Gram-negatif izolatlarda, oral kullanımı olan antimikrobikler içinde nitrofurantoin (NF) en düşük direnç oranına sahipti (sırasıyla %2,7 ve %12,1). Öte yandan Gram-pozitif bakteriler için ampisilin (%6,3), Gram-negatif bakteriler için ise sefuroksim (%25,9) en düşük direnç oranlarına sahip diğer oral tedavi seçenekleri olarak belirlendi. Sonuç: Yetişkin yaş grubundaki poliklinik hastalarımızın alt ÜSE enfeksiyonlarında NF en geniş 
Introduction
Enterobacteriacea are responsible for the majority of symptomatic lower urinary tract infections (UTI). Escherichia coli is the most reported pathogen (80-95%) in both nosocomial and community-acquired UTI. In suspicion of UTI, clinicians start empirical antibiotic therapy before the antibiotic susceptibility test results. Antibiotics are prescribed for about five million patients with UTI per year in Turkey. The misuse and overuse of antibiotics for either therapy or prophylaxis speeds up the development of resistance. 1 The aims of the study are to investigate the distribution and the antibiotic resistance profile of the microorganisms in our UTI outpatients during 2011-2012 period; to determine the most appropriate current empirical therapy choices.
Materials and Methods
Culture and susceptibility test results of 14096 urine samples sent from outpatient clinics with presumptive UTI diagnosis between April 2011 and March 2012 were reviewed. Pediatric age group (<15 years old) was excluded because of the limited number of the patient data. Culture and identification tests were done by conventional (IMVIC test)/ semi-automatic (API 20 E, bio Merioux, France) and automatic methods (VITEK 2, bio Merieux, France). Patients who had pyuria and UTI suspicion were selected for the study. Growth of one or two types of bacteria above 10 5 cfu/mL detected in culture was considered as significant. Antibiotic susceptibility tests were performed by Kirby-Bauer disc diffusion method according to the recommendations of CLSI (Clinical Laboratory Standarts Institute). 2 The production of extended spectrum beta-lactamases (ESBL) was analyzed by double disc synergy method. 3 For E.coli, the highest resistance rates were against ampisilin and cephalothin among all tested oral drugs (62.5% and 44.8% respectively). Amikacin was determined as the second effective agent after imipenem for parenteral therapy. These results were rather similar to those of the other members of Enterobacteriaceae.
No E.coli isolate had resistance against imipenem or ertapenem. The extended spectrum beta-lactamase (ESBL) prevalence was 23.2% in E.coli, 25.4% in K.pneumoniae and 2.6% in Proteus mirabilis. The overall antibiotic resistance rates of ESBL-positive E.coli isolates were statistically higher than the ESBL-negative ones except for amikacin (p=0.69). Likewise, ESBL-positive K.pneumoniae isolates had higher resistance rates than the negative ones except for imipenem (p=0.267) and ertapenem (p=1.000) ( Table 2 ). To obtain a more general consideration, the isolates were also grouped into three categories as Gram-positives, Gram-negatives and P.aeruginosa, and antibiotic resistance rates were calculated for each group ( 
Discussion
E.coli has always been the most common pathogen among UTI pathogens (60-90%) for both sexes and for all ages. Especially in spring, CNS is the second isolate responsible for UTIs of sexually active young women. E.coli is still the dominant agent although the percentage of P.aeruginosa and other gram-negative bacilli and enterococci has begun to increase in complicated infections. 1 E.coli was the most frequent agent (64.2%) isolated from outpatients above 15 years old in this study. This is consistent with the results of several studies from Turkey and the other countries. The other isolates ensuing E.coli were CNS (5.2%), enterococci (4.9%) and Pseudomonas spp. (3.3%). In several domestic studies, isolation frequencies of these species in UTI were reported as 1-10%, 2.5-6% and 0.3-7.8% respectively. [4] [5] [6] [7] [8] [9] For all of the three species, our results are parallel to those of both domestic and international studies. [6] [7] [8] [9] Most of the present literature of UTI are about E.coli, the most frequent UTI agent. The resistance rates of E.coli are continuously rising because of the misuse of the antibiotics both in Turkey and in the world. As there was no significant difference between E.coli and Enterobacteriaceae spp. in resistance rates, we preferred to give the total resistance percentage of Enterobacteriaceaespp in this study. According to our results, the most effective antibiotics were carbapenems especially imipenem for Enterobacteriaceae spp. and Pseudomonas spp. Consistently, rare or no Pseudomonas or Enterobacteriaceae isolates were reported as resistant against carbapenems in other domestic studies. 15 Amikacin (0.9% resistance) was the most and tobramycin was the least (18% resistance) effective agent among the tested aminoglycosides (amikacin, gentamicin, tobramycin) for enteric bacteria. In some other Turkish reports, amikacin resistance ranges between 0.6 and 10.3% for E.coli and this drug happens to be the second effective antibiotic following carbapenems. [1] [2] [3] [4] [5] [6] The reason of the low amikacin resistance in both Enterobacteriaceae spp. and Pseudomonas spp is thought to be the restricted reporting of antibiogram results .
The resistance rates of enteric bacteria against cephalosporins varied between 5.1% (cefoxitin) and 45.7% (cephalothin) in our study. Despite its relatively high resistance rate determined as 25.9%, cefuroxime came up as the second effective oral drug. Sağlam et al. found a similar resistance rate for cefuroxime, while, several other studies reported quite different rates ranged between 17.8% and 54.1% . 13, 14 Ceftazidime and cefepime are the selected cephalosporins tested for Pseudomonas spp. According to our results, ceftazidime was one of the most effective antibiotics which had an equal susceptibility with imipenem (4.5%). Cefepime had a resistance rate of (6.3%). The second and third effective agents were Piperacillin-tazobactam (P/T) and piperacilline for Pseudomonas spp. However, the relevant literature is not enough to make a comment for this situation.
We found the resistance rates of ampicilline and AMC as 69.6% and 28.6 respectively. In a metaanalysis by Aykan et al. these rates were determined as 62% and 34%. 15 The usage of different prescribed antibiotics in studied populations might be the reason of the different rates especially for AMC resistance. According to our results AMC can be considered as an alternative for cefuroxime among orally administered drugs.
The usage of beta-lactam antibiotics and extended spectrum cephalosporins have been increased during the last 20 years. This made easier the raising of ESBL-positive microorganisms, especially resistant E.coli and K.pneumoniae strains. Beta lactamases, especially ESBL are responsible for the majority of resistance against beta-lactams. 16 The percentage of ESBL-positive E.coli in UTI was reported as 5-26% by several studies from Turkey. 14 In our study, ESBL positivity rates (23.2% of E.coli and 25.4% of K.pneumonia isolates) were a little higher than those of domestic and outsider reports. 6, 12, 14, 16 This might be partially due to the admission of some inadequately treated patients with resistant strains to our hospital which is a tertiary care institute.
Traditionally, nitrofurantoin, fluoroquinolons, TMP-SMX, phosphomycine and betalactams (except ampicillin and amoxicillin) are the recommended antibiotics for adult UTIs. These agents are preferred because of their pharmacokinetic properties and broad antimicrobial spectrums covering most of the gram-positive and negatives. 4 TMP-SMX has been recommended as the first choice for treatment of UTI for a long time, however it is placed in lower ranges of effectiveness alignment with its really high resistance rate (35.1%) in our study. Several studies from Turkey also reported very high resistance rates (39-47%) against TMP-SMX. 1, 4, 14, 16 Similarly, TMP-SMX resistance rates vary a lot in other regions of the world. Karlowsky et al. reported it as 66.5% in USA and Canada; 17 while European countries have relatively lower rates ranging between 17.1% and 40% . 13 Following the appearance of high resistance rates against TMP-SMX, floroquinolons substituted it as an effective treatment alternative. According to the data of the 2009-2010 SMART programme, the regional resistance of quinolons were 23.5% in North America, 29.4% in Europe, 33.2% in Asia, and 38.7% in Latin America. In the same study, the range of resistance varied a lot; from 6% (Estonia) to 75% (India), with Turkey being the fifth country having a rate of 45%. 18 The quinolon resistance was 32.8% in our study. Lower and higher rates ranging between 23.6% and 70% were reported from several studies in Turkey. 4, 15, 17 Ciprofloxacin was found to be the less effective member of the group to Pseudomonas spp. in our study. The quinolon resistance was very high both for gram-positives and negatives with a close percentage to the resistance of TMP-SMX. It is a clear indicator of irrational antibiotic usage that, the quinolons had begun to be used in treatment long time after TMP-SMX but got the same resistance rates in a shorter time than it.
NF has had a limited usage in recent years, and is not included into the antibiogram list of many care centers. Whereas, it has been used in USA since 1953, in spite of its rarely seen serious side effects. 19 It is still very effective against the uropathogens. 20 Considering the increase of the resistance to the other agents, NF is on the agenda again. Notably, it was the most effective antimicrobial for all isolates in our study. The resistance of NF was reported 3.6-8.4% for outpatients. 4, 7 Expectedly, resistance of ESBL-positive isolates to it was found higher. Gözel et al. reported a slope down in NF resistance (from 4% to 0%) of ESBL-positive E.coli isolates in 2006-2010 period. 16 NF is preferred in the primary health care facilities for its high effectiveness, low cost and low resistance especially in the regions which have high resistance rates of quinolons and TMP-SMX. 19, 20 E.faecalis and E.faecium not only have chromosomal resistance to many antibiotics but also have tendency to gain resistance easily to the other antimicrobial agents. Being quite similar to our results, Rudy et al. reported resistance rates of E.faecalis isolates from urine samples to glycopeptides and NF as 0% and to penicilin as 4%. In that study, the less effective antibiotic to Enterococcus spp. was found as ciprofloxacin. 21 There are several studies from Turkey including parallel results. 6, 22 We found no resistance to cefotaxime and vancomycin in gram-positive isolates and the most effective oral antimicrobials to these microrganisms were NF and ampicilline, in our study.
According to our one year data of culture and antibiogram, NF appears as the most effective oral drug for outpatients with UTI in adults for empiric therapy. Cefuroxim can be considered as the second effective oral choice because ampicillin-sensitive gram-positive isolates (except Enterococcus spp) would also be sensitive to it. If the regional resistance is below 20%, NF and TMP-SMX, is suggested as first or second choice in UTI treatment in antimicrobial therapy guidelines like Sanford and IDSA. 23, 24 However, TMP-SMX resistance was found 35% in our population; consequently it is not a suitable option for us.
According to the data of Turkish Ministry of Health, 20% of the sold drugs are antibiotics in Turkey. Rational drug use is an important concern for all drug groups but it has a special importance for antimicrobials. 25 Culture and antibiogram tests are generally not recommended for community-acquired UTI because of the costeffectivity reason. However, as the resistance of TMP-SMX, ampicillin and quinolones are over 20% for especially E.coli isolates widely in Turkey, it seems as the safer and more effective option to do culture and antibiogram tests before antimicrobial treatment of UTI whichever care facility the patient admits.
